HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miyazaki, S. Articles by Miyazaki, J.-i. Search for Related Content PubMed PubMed Citation Articles by Miyazaki, S. Articles by Miyazaki, J.-i. Social Bookmarking                What's this?

Regulated Expression of pdx-1 Promotes In Vitro Differentiation of Insulin-Producing Cells From Embryonic Stem Cells

From the Division of Stem Cell Regulation Research, Osaka University Graduate School of Medicine, Suita, Japan

Embryonic stem (ES) cells can differentiate into many cell types. Recent reports have shown that ES cells can differentiate into insulin-producing cells. However, the differentiation is not efficient enough to produce insulin-secreting cells for future therapeutic use. Pdx-1, a homeodomain-containing transcription factor, is a crucial regulator for pancreatic development. We established an ES cell line in which exogenous pdx-1 expression was precisely regulated by the Tet-off system integrated into the ROSA26 locus. Using this cell line, we examined the effect of pdx-1 expression during in vitro differentiation via embryoid body formation. The results showed that pdx-1 expression clearly enhanced the expression of the insulin 2, somatostatin, Kir6.2, glucokinase, neurogenin3, p48, Pax6, PC2, and HNF6 genes in the resulting differentiated cells. Immunohistochemical examination also revealed that insulin was highly produced in most of the differentiated ES cells. Thus, exogenous expression of pdx-1 should provide a promising approach for efficiently producing insulin-secreting cells from human ES cells for future therapeutic use in diabetic patients.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. M. Keller, S. McWeeney, A. Arsenlis, J. Drouin, C. V. E. Wright, H. Wang, C. B. Wollheim, P. White, K. H. Kaestner, and R. H. Goodman Characterization of Pancreatic Transcription Factor Pdx-1 Binding Sites Using Promoter Microarray and Serial Analysis of Chromatin Occupancy J. Biol. Chem., November 2, 2007; 282(44): 32084 - 32092. [Abstract] [Full Text] [PDF]

				C.-G. Liew, J. S. Draper, J. Walsh, H. Moore, and P. W. Andrews Transient and Stable Transgene Expression in Human Embryonic Stem Cells Stem Cells, June 1, 2007; 25(6): 1521 - 1528. [Abstract] [Full Text] [PDF]

				R. F. Luco, M. A. Maestro, N. del Pozo, W. M. Philbrick, P. P. de la Ossa, and J. Ferrer A Conditional Model Reveals That Induction of Hepatocyte Nuclear Factor-1{alpha} in Hnf1{alpha}-Null Mutant {beta}-Cells Can Activate Silenced Genes Postnatally, Whereas Overexpression Is Deleterious. Diabetes, August 1, 2006; 55(8): 2202 - 2211. [Abstract] [Full Text] [PDF]

				S. P. Raikwar, T. Mueller, and N. Zavazava Strategies for Developing Therapeutic Application of Human Embryonic Stem Cells Physiology, February 1, 2006; 21(1): 19 - 28. [Abstract] [Full Text] [PDF]

				J. Mao, J. Barrow, J. McMahon, J. Vaughan, and A. P. McMahon An ES cell system for rapid, spatial and temporal analysis of gene function in vitro and in vivo Nucleic Acids Res., October 12, 2005; 33(18): e155 - e155. [Abstract] [Full Text] [PDF]

				G. K.C. Brolen, N. Heins, J. Edsbagge, and H. Semb Signals From the Embryonic Mouse Pancreas Induce Differentiation of Human Embryonic Stem Cells Into Insulin-Producing {beta}-Cell-Like Cells Diabetes, October 1, 2005; 54(10): 2867 - 2874. [Abstract] [Full Text] [PDF]

				T. Fujikawa, S.-H. Oh, L. Pi, H. M. Hatch, T. Shupe, and B. E. Petersen Teratoma Formation Leads to Failure of Treatment for Type I Diabetes Using Embryonic Stem Cell-Derived Insulin-Producing Cells Am. J. Pathol., June 1, 2005; 166(6): 1781 - 1791. [Abstract] [Full Text] [PDF]

				G. Keller Embryonic stem cell differentiation: emergence of a new era in biology and medicine Genes & Dev., May 15, 2005; 19(10): 1129 - 1155. [Abstract] [Full Text] [PDF]

				H. Kaneto, Y. Nakatani, T. Miyatsuka, T.-a. Matsuoka, M. Matsuhisa, M. Hori, and Y. Yamasaki PDX-1/VP16 Fusion Protein, Together With NeuroD or Ngn3, Markedly Induces Insulin Gene Transcription and Ameliorates Glucose Tolerance Diabetes, April 1, 2005; 54(4): 1009 - 1022. [Abstract] [Full Text] [PDF]

				S. J. Micallef, M. E. Janes, K. Knezevic, R. P. Davis, A. G. Elefanty, and E. G. Stanley Retinoic Acid Induces Pdx1-Positive Endoderm in Differentiating Mouse Embryonic Stem Cells Diabetes, February 1, 2005; 54(2): 301 - 305. [Abstract] [Full Text] [PDF]

				C. J Burns, S. J Persaud, and P. M Jones Stem cell therapy for diabetes: do we need to make beta cells? J. Endocrinol., December 1, 2004; 183(3): 437 - 443. [Abstract] [Full Text] [PDF]